Answers are grounded in this paper and cite their sources.
Z-drugs seem to be attractive because experiential knowledge overemphasizes their benefits and fails to take risks such as drug-related falls and confusion into account. Difficulties to judge a drug's risk-benefit ratio do not prevent doctors and nurses from using them. Interventions for reducing Z-drug usage should incorporate local quality assurance data about relevant patient risks.
No takes yet. Share an insight, caveat, or question.
Heinemann et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: